The death of insu
lin-secreting
![](/images/gifchars/beta2.gif)
-cells that causes type I diabetes mellitus (DM) occurs in partby apoptosis, and apoptosis also contributes to progressive
![](/images/gifchars/beta2.gif)
-cell dysfunction in type II DM. Recentreports indicate that ER stress-induced apoptosis contributes to
![](/images/gifchars/beta2.gif)
-cell loss in diabetes. Agents that depleteER calcium levels induce
![](/images/gifchars/beta2.gif)
-cell apoptosis by a process that is independent of increases in [Ca
2+]
i. Herewe report that the SERCA inhibitor thapsigargin induces apoptosis in INS-1 insu
linoma cells and thatthis is inhibited by a bromoenol lactone (BEL) inhibitor of group VIA calcium-independent phospholipaseA
2 (iPLA
2![](/images/gifchars/beta2.gif)
). Overexpression of iPLA
2![](/images/gifchars/beta2.gif)
amplifies thapsigargin-induced apoptosis of INS-1 cells, andthis is also suppressed by BEL. The magnitude of thapsigargin-induced INS-1 cell apoptosis correlateswith the level of iPLA
2![](/images/gifchars/beta2.gif)
expression in various cell
lines, and apoptosis is associated with stimulation ofiPLA
2![](/images/gifchars/beta2.gif)
activity, perinuclear accumulation of iPLA
2![](/images/gifchars/beta2.gif)
protein and activity, and caspase-3-catalyzed cleavageof full-length 84 kDa iPLA
2![](/images/gifchars/beta2.gif)
to a 62 kDa product that associates with nuclei. Thapsigargin also inducesceramide accumulation in INS-1 cells, and this response is amplified in cells that overexpress iPLA
2![](/images/gifchars/beta2.gif)
.These findings indicate that iPLA
2![](/images/gifchars/beta2.gif)
participates in ER stress-induced apoptosis, a pathway that promotes
![](/images/gifchars/beta2.gif)
-cell death in diabetes.